InvestorsHub Logo
Followers 8
Posts 1427
Boards Moderated 0
Alias Born 06/30/2016

Re: numbersarefun post# 31077

Thursday, 11/02/2017 8:05:01 AM

Thursday, November 02, 2017 8:05:01 AM

Post# of 38634
Numbers, this is what the latest discussions have been about regarding IPCI wasting it's pipeline.

IPCI should have partnered Regabatin 2 years ago after its IND and they knew they needed extensive and costly testing and therefore needed a partner.

Now, IF they ever partner it, it will take roughly 3 years to complete the tests a year to get the application through the process and now they will get sued by Pfizer as Pfizer wll want to protect its market share and therefore IPCI infringed on their patent. Thereby stalling it further for a another good 18 months.

currently, I see Regabatin as a dead issue. Its easily 7 years out based on the above and then that assumes an immediate partnership. one has to ask, why wasn't it partnered already? My guess is Odidi can not secure the deal. he probably wanted too much money, felt they were "ripping him off" and then decided to go it alone like Rexista and make it "plug and Play" using funds from a Rexista partnership to do the tests himself.

If I am correct then we see no progress on it until after Rexista is settled and marketed and thats another year and half down the road before that 7 year clock starts ticking.

so, I am no longer holding hope for Regabatin in the near future. Odidi will squander another asset away.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPCI News